India opportunity screening
Delivered against the family's written mandate and the evidence available for the specific opportunity.
For Singapore family offices and private investors, VIV complements regional investment teams with India-specific diligence, direct and co-investment challenge, portfolio interventions and local monitoring.
Find where capital can be protected, improved or realized.
The family is the client; VIV is not paid by a startup to sell the deal.
Verify what is owned, what changed and what evidence supports the investment case.
VIV is not simply a source of Indian deals. The model connects a Singapore family's investment mandate and operating capabilities with independently verified Indian companies — and can help portfolio companies access relevant customers, suppliers, distribution, expertise or strategic buyers when both sides consent.
The exact work depends on the family's existing exposure, direct-investment appetite, sector knowledge, team depth and India objectives.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
These are positioning themes for discussion, not claims that every family in Singapore follows the same mandate.
VIV first captures the family's actual mandate and capabilities before sourcing or introducing opportunities.
No public deal marketplace. No mass introductions. The process begins privately with what the family wants to own, avoid, verify or solve.
Ticket, sectors, stage, geography, return/risk expectations, direct vs fund exposure, strategic capabilities and exclusions.
Identify relevant opportunities or existing exposures, then verify management, financial, customer, market and ownership evidence.
Show what supports the case, what contradicts it, what remains unknown and what conditions should precede a cheque or follow-on.
Monitor changes, activate useful cross-border capabilities, review follow-ons and prepare liquidity or strategic-exit pathways.
Verified corridor facts are separated from VIV's proposed service thesis. Sector priorities remain hypotheses until the family's mandate is known.
Singapore was India's largest FDI source in FY2024-25 with $14.94B of FDI flows.
Official source ↗Bilateral trade reached $34.3B in 2024-25.
Official source ↗Customers, distribution, technology, manufacturing, expertise, strategic relationships or patient capital.
VIV tests investment quality and strategic synergy separately. One does not excuse weakness in the other.
A Singapore FO already has an investment team but lacks India bandwidth. VIV becomes the local specialist for references, operating verification, follow-ons and interventions.
Service scenario; not a client case, investment offer or performance claim.
Tell us enough to understand the problem. We use the information to route the conversation to the relevant VIV service; it is not a public deal submission.
VIV treats corridor access as an investment-and-execution problem, not a list of introductions. The work separates commercial underwriting from regulated legal, tax, valuation and securities work.
Cross-border structures can involve Singapore securities/fund-management boundaries, Companies Act, tax, competition and India FEMA/FDI/ODI. VIV keeps regulated advice, fund structuring and transaction execution with appropriately licensed/qualified parties.
Return underwriting separates company performance, entry valuation, dilution, SGD/INR, tax and time-to-exit. Regional-holding structures are assessed for substance and economics, not assumed to create value by themselves.
Strategic M&A, regional buyers, secondary transactions and later institutional rounds are common pathways to test; shareholder rights and actual buyer appetite determine feasibility.
Risks include high-quality assets priced aggressively, regional expansion assumptions, regulatory substance, dilution and limited liquidity below institutional scale. VIV uses valuation ranges, customer references, governance review and exit mapping.
Country dynamics are a VIV commercial diligence framework, not legal, tax or regulated investment advice. Current transaction-specific requirements must be confirmed by appropriately qualified advisers before execution.
Investor and family appetite is retained by sector, stage, ticket and Southeast-Asia strategic relevance rather than treated as generic regional capital.
Regional customers, operators, strategic partners and capital relationships are mapped by geography and operating capability.
Evidence from customer validation, expansion assumptions, investor objections and outcomes improves later India–Singapore mandates.